Header5

The simple corporate scheme behind massive US Brand Drug Prices

My 7-year whistleblower effort
"People Before Profits"

Opening “Pandora’s Box”: Witnesses Galore

This Simple "Fee" Price Collusion Scheme has been an "Open Secret" for Many Years Now

 

  • The drug prices have doubled and taxpayer harm has tripled since the initial Whistleblower case was filed in January 2014
    • $175+ billion over the past decade-plus (and rising every day) just for the 22 major U.S brand drugs in the Whistleblower cases

Witnesses Galore

    • Lots of “industry insiders” can quickly verify the straightforward, centralized “pharma fee” scheme
    • Pharma and health insurer/PBM senior executives
      • Many provided in the Whistleblower Court documents, but not pursued by DOJ
    • Industry legal and consultant advisers
      • Many provided in the Whistleblower Court documents, but not pursued by DOJ
    • Many other healthcare experts closely affiliated with the pharma and health insurance/PBM industries

THE DEPARTMENT OF JUSTICE (DOJ) REPEATEDLY ADMITTED NOT PURSUING THE 40-45 FIRSTHAND INSIDERS PROVIDED IN THE WHISTLEBLOWER LEGAL DOCUMENTS FROM THE ONE-OF-KIND OCTOBER 2013 “PHARMA FEE” CONFERENCE

DOJ REPEATEDLY ADMITTED INTERVIEWING ONLY ONE WITNESS (AN UNNAMED PBM EXECUTIVE) UNDER OATH DURING THE GOVERNMENT'S 4+ YEAR WHISTLEBLOWER INVESTIGATION

DOJ REPEATEDLY ADMITTED THAT NOT A SINGLE PHARMACEUTICAL EXECUTIVE WAS INTERVIEWED UNDER OATH DURING THE GOVERNMENT'S 4+ YEAR WHISTLEBLOWER INVESTIGATION

 

Receive the Latest News

Your email is 100% safe.
Your privacy will be respected.
!
!
Something went wrong. Please check your entries and try again.
Scroll to Top